Docetaxel Injection 120mg/6ml (RTU) | Third Party Manufacturing | Medizia Biotech

Docetaxel Injection 120mg/6ml (RTU) is a ready-to-use sterile anti-cancer chemotherapy injection used in the treatment of various cancers, including breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head & neck cancer. The ready-to-use (RTU) formulation eliminates the need for reconstitution, ensuring convenience, accuracy, and reduced preparation time in hospitals and oncology centers.

Medizia Biotech is a trusted Docetaxel Injection manufacturer in India, offering third party manufacturing, contract manufacturing, and bulk manufacturing services for oncology injectables. Our state-of-the-art WHO-GMP compliant manufacturing facilities follow stringent quality standards to deliver safe, effective, and high-quality pharmaceutical products for domestic and international markets.

We provide comprehensive manufacturing solutions, including product development, customized packaging, private labeling, regulatory documentation support, and timely delivery. Whether you require small production batches or large commercial quantities, Medizia Biotech offers reliable and cost-effective manufacturing services tailored to your business needs.

Why Choose Medizia Biotech?

• WHO-GMP compliant manufacturing facility
• Third party manufacturing for oncology injectables
• Contract manufacturing with customized branding
• Ready stock and bulk manufacturing support
• Export-quality pharmaceutical products
• Strict quality control and regulatory compliance
• Timely production and nationwide supply
• Dedicated support for hospitals, distributors, and healthcare institutions

Medizia Biotech is committed to delivering premium-quality oncology formulations with consistent quality, competitive pricing, and dependable manufacturing solutions for pharmaceutical businesses across India and global markets.